Page 100 - Read Online

Page 16 of 18 Browne et al. Vessel Plus 2024;8:19 https://dx.doi.org/10.20517/2574-1209.2023.126

surgery: the aggressive cholesterol therapy to inhibit vein graft events randomized clinical trial. J Thorac Cardiovasc Surg
2019;157:151-61.e1. DOI PubMed
15. Kulik A, Le May MR, Voisine P, et al. Aspirin plus clopidogrel versus aspirin alone after coronary artery bypass grafting: the
clopidogrel after surgery for coronary artery disease (CASCADE) trial. Circulation 2010;122:2680-7. DOI
16. Zhao Q, Zhu Y, Xu Z, et al. Effect of ticagrelor plus aspirin, ticagrelor alone, or aspirin alone on saphenous vein graft patency 1 year
after coronary artery bypass grafting: a randomized clinical trial. JAMA 2018;319:1677-86. DOI PubMed PMC
17. Willemsen LM, Janssen PWA, Peper J, et al. Effect of adding ticagrelor to standard aspirin on saphenous vein graft patency in patients
undergoing coronary artery bypass grafting (POPular CABG): a randomized, double-blind, placebo-controlled trial. Circulation
2020;142:1799-807. DOI
18. Alexander JH, Hafley G, Harrington RA, et al; PREVENT IV Investigators. Efficacy and safety of edifoligide, an E2F transcription
factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized
controlled trial. JAMA 2005;294:2446-54. DOI
19. Kulik A, Abreu AM, Boronat V, Kouchoukos NT, Ruel M. Ticagrelor versus aspirin and vein graft patency after coronary bypass: a
randomized trial. J Card Surg 2022;37:563-70. DOI
20. Buxton BF, Raman JS, Ruengsakulrach P, et al. Radial artery patency and clinical outcomes: five-year interim results of a randomized
trial. J Thorac Cardiovasc Surg 2003;125:1363-71. DOI
21. Deb S, Cohen EA, Singh SK, Une D, Laupacis A, Fremes SE; RAPS Investigators. Radial artery and saphenous vein patency more
than 5 years after coronary artery bypass surgery: results from RAPS (Radial Artery Patency Study). J Am Coll Cardiol 2012;60:28-
35. DOI
22. Collins P, Webb CM, Chong CF, Moat NE; Radial Artery Versus Saphenous Vein Patency (RSVP) Trial Investigators. Radial artery
versus saphenous vein patency randomized trial: five-year angiographic follow-up. Circulation 2008;117:2859-64. DOI
23. Petrovic I, Nezic D, Peric M, et al. Radial artery vs saphenous vein graft used as the second conduit for surgical myocardial
revascularization: long-term clinical follow-up. J Cardiothorac Surg 2015;10:127. DOI PubMed PMC
24. Nasso G, Coppola R, Bonifazi R, Piancone F, Bozzetti G, Speziale G. Arterial revascularization in primary coronary artery bypass
grafting: direct comparison of 4 strategies--results of the stand-in-Y mammary study. J Thorac Cardiovasc Surg 2009;137:1093-100.
DOI PubMed
25. Song SW, Sul SY, Lee HJ, Yoo KJ. Comparison of the radial artery and saphenous vein as composite grafts in off-pump coronary
artery bypass grafting in elderly patients: a randomized controlled trial. Korean Circ J 2012;42:107-12. DOI PubMed PMC
26. Gaudino M, Bakaeen F, Benedetto U, et al. Use rate and outcome in bilateral internal thoracic artery grafting: insights from a
systematic review and meta-analysis. J Am Heart Assoc 2018;7:e009361. DOI PubMed PMC
27. Deng MX, Lia H, Lee G, et al. Angiographic patency of coronary artery bypass conduits: an updated network meta-analysis of
randomized trials. Braz J Cardiovasc Surg 2022;37:7-31. DOI PubMed PMC
28. Yokoyama Y, Takagi H, Kuno T. Graft patency of a second conduit for coronary artery bypass surgery: a network meta-analysis of
randomized controlled trials. Semin Thorac Cardiovasc Surg 2022;34:102-9. DOI PubMed
29. Gaudino M, Audisio K, Di Franco A, et al. Radial artery versus saphenous vein versus right internal thoracic artery for coronary artery
bypass grafting. Eur J Cardiothorac Surg 2022;62:ezac345. DOI
30. Taggart DP, Benedetto U, Gerry S, et al; Arterial Revascularization Trial Investigators. Bilateral versus single internal-thoracic-artery
grafts at 10 years. N Engl J Med 2019;380:437-46. DOI
31. Lamy A, Devereaux PJ, Prabhakaran D, et al; CORONARY Investigators. Five-year outcomes after off-pump or on-pump coronary-
artery bypass grafting. N Engl J Med 2016;375:2359-68. DOI PubMed
32. Hayward PA, Gordon IR, Hare DL, et al. Comparable patencies of the radial artery and right internal thoracic artery or saphenous vein
beyond 5 years: results from the radial artery patency and clinical outcomes trial. J Thorac Cardiovasc Surg 2010;139:60-7. DOI
33. Gaudino M, Benedetto U, Fremes S, et al; RADIAL Investigators. Radial-artery or saphenous-vein grafts in coronary-artery bypass
surgery. N Engl J Med 2018;378:2069-77. DOI
34. Gaudino M, Lorusso R, Rahouma M, et al. Radial artery versus right internal thoracic artery versus saphenous vein as the second
conduit for coronary artery bypass surgery: a network meta-analysis of clinical outcomes. J Am Heart Assoc 2019;8:e010839. DOI
PubMed PMC
35. de Oliveira Sá MPB, Ferraz PE, Escobar RR, et al. Patency of skeletonized versus pedicled internal thoracic artery in coronary bypass
graft surgery: a systematic review, meta-analysis and meta-regression. Int J Surg 2014;12:666-72. DOI
36. Hayashi Y, Ito T, Maekawa A, et al. Effect of modified proximal anastomosis of the free right internal thoracic artery: piggyback and
foldback techniques. Interact Cardiovasc Thorac Surg 2016;22:265-72. DOI PubMed PMC
37. Shroyer AL, Grover FL, Hattler B, et al; Veterans affairs randomized on/off bypass (ROOBY) study group. On-pump versus off-pump
coronary-artery bypass surgery. N Engl J Med 2009;361:1827-37. DOI
38. Antonopoulos AS, Odutayo A, Oikonomou EK, et al; SAFINOUS-CABG (Saphenous Vein Graft Failure - An Outcomes Study in
Coronary Artery Bypass Grafting) group. Development of a risk score for early saphenous vein graft failure: an individual patient data
meta-analysis. J Thorac Cardiovasc Surg 2020;160:116-27.e4. DOI
39. Tian M, Wang X, Sun H, et al. No-touch versus conventional vein harvesting techniques at 12 months after coronary artery bypass
grafting surgery: multicenter randomized, controlled trial. Circulation 2021;144:1120-9. DOI
40. Post Coronary Artery Bypass Graft Trial Investigators. The effect of aggressive lowering of low-density lipoprotein cholesterol levels